These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Baker NL; Mörgelin M; Peat R; Goemans N; North KN; Bateman JF; Lamandé SR Hum Mol Genet; 2005 Jan; 14(2):279-93. PubMed ID: 15563506 [TBL] [Abstract][Full Text] [Related]
5. A heterozygous splice site mutation in COL6A1 leading to an in-frame deletion of the alpha1(VI) collagen chain in an italian family affected by bethlem myopathy. Pepe G; Giusti B; Bertini E; Brunelli T; Saitta B; Comeglio P; Bolognese A; Merlini L; Federici G; Abbate R; Chu ML Biochem Biophys Res Commun; 1999 May; 258(3):802-7. PubMed ID: 10329467 [TBL] [Abstract][Full Text] [Related]
6. Detection of common and private mutations in the COL6A1 gene of patients with Bethlem myopathy. Lucioli S; Giusti B; Mercuri E; Vanegas OC; Lucarini L; Pietroni V; Urtizberea A; Ben Yaou R; de Visser M; van der Kooi AJ; Bönnemann C; Iannaccone ST; Merlini L; Bushby K; Muntoni F; Bertini E; Chu ML; Pepe G Neurology; 2005 Jun; 64(11):1931-7. PubMed ID: 15955946 [TBL] [Abstract][Full Text] [Related]
8. Missense mutation in a von Willebrand factor type A domain of the alpha 3(VI) collagen gene (COL6A3) in a family with Bethlem myopathy. Pan TC; Zhang RZ; Pericak-Vance MA; Tandan R; Fries T; Stajich JM; Viles K; Vance JM; Chu ML; Speer MC Hum Mol Genet; 1998 May; 7(5):807-12. PubMed ID: 9536084 [TBL] [Abstract][Full Text] [Related]
9. COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy. Pepe G; Lucarini L; Zhang RZ; Pan TC; Giusti B; Quijano-Roy S; Gartioux C; Bushby KM; Guicheney P; Chu ML Ann Neurol; 2006 Jan; 59(1):190-5. PubMed ID: 16278855 [TBL] [Abstract][Full Text] [Related]
10. Novel mutations in collagen VI genes: expansion of the Bethlem myopathy phenotype. Scacheri PC; Gillanders EM; Subramony SH; Vedanarayanan V; Crowe CA; Thakore N; Bingler M; Hoffman EP Neurology; 2002 Feb; 58(4):593-602. PubMed ID: 11865138 [TBL] [Abstract][Full Text] [Related]
11. Kinked collagen VI tetramers and reduced microfibril formation as a result of Bethlem myopathy and introduced triple helical glycine mutations. Lamandé SR; Mörgelin M; Selan C; Jöbsis GJ; Baas F; Bateman JF J Biol Chem; 2002 Jan; 277(3):1949-56. PubMed ID: 11707460 [TBL] [Abstract][Full Text] [Related]
12. Evidence for locus heterogeneity in the Bethlem myopathy and linkage to 2q37. Speer MC; Tandan R; Rao PN; Fries T; Stajich JM; Bolhuis PA; Jöbsis GJ; Vance JM; Viles KD; Sheffield K; James C; Kahler SG; Pettenati M; Gilbert JR; Denton PH; Yamaoka LH; Pericak-Vance MA Hum Mol Genet; 1996 Jul; 5(7):1043-6. PubMed ID: 8817344 [TBL] [Abstract][Full Text] [Related]
13. Primary collagen VI deficiency is the second most common congenital muscular dystrophy in Japan. Okada M; Kawahara G; Noguchi S; Sugie K; Murayama K; Nonaka I; Hayashi YK; Nishino I Neurology; 2007 Sep; 69(10):1035-42. PubMed ID: 17785673 [TBL] [Abstract][Full Text] [Related]
14. Collagen VI status and clinical severity in Ullrich congenital muscular dystrophy: phenotype analysis of 11 families linked to the COL6 loci. Demir E; Ferreiro A; Sabatelli P; Allamand V; Makri S; Echenne B; Maraldi M; Merlini L; Topaloglu H; Guicheney P Neuropediatrics; 2004 Apr; 35(2):103-12. PubMed ID: 15127309 [TBL] [Abstract][Full Text] [Related]
15. Alport syndrome. Molecular genetic aspects. Hertz JM Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970 [TBL] [Abstract][Full Text] [Related]
16. Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem. Zou Y; Zhang RZ; Sabatelli P; Chu ML; Bönnemann CG J Neuropathol Exp Neurol; 2008 Feb; 67(2):144-54. PubMed ID: 18219255 [TBL] [Abstract][Full Text] [Related]
18. Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. Lampe AK; Dunn DM; von Niederhausern AC; Hamil C; Aoyagi A; Laval SH; Marie SK; Chu ML; Swoboda K; Muntoni F; Bonnemann CG; Flanigan KM; Bushby KM; Weiss RB J Med Genet; 2005 Feb; 42(2):108-20. PubMed ID: 15689448 [TBL] [Abstract][Full Text] [Related]
19. Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families. Peat RA; Baker NL; Jones KJ; North KN; Lamandé SR Neuromuscul Disord; 2007 Jul; 17(7):547-57. PubMed ID: 17537636 [TBL] [Abstract][Full Text] [Related]
20. Mutations in the collagen XII gene define a new form of extracellular matrix-related myopathy. Hicks D; Farsani GT; Laval S; Collins J; Sarkozy A; Martoni E; Shah A; Zou Y; Koch M; Bönnemann CG; Roberts M; Lochmüller H; Bushby K; Straub V Hum Mol Genet; 2014 May; 23(9):2353-63. PubMed ID: 24334769 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]